USA - NASDAQ:ALXN -
ChartMill assigns a Buy % Consensus number of 66% to ALXN. The Buy consensus is the weighted average rating of the current analysts ratings.
13 analysts have analysed ALXN and the average price target is 180.9 null. This implies a price decrease of -0.87% is expected in the next year compared to the current price of 182.5.
The consensus rating for Alexion Pharm Inc (ALXN) is 66.2 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering Alexion Pharm Inc (ALXN) is 13.